Physician
Pars Neurosurgical Associates, INC
Pars Neurosurgical Associates, INC was paid $1.55M by Medicaid between Jan 2018 and Sep 2024, across 66 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 46% of everything it billed.
33Billing provider infoPARS NEUROSURGICAL ASSOCIATES, INC
PARKERSBURG, WV 26101
PARKERSBURG, WV 26101
33aNPI1457396152assigned 06/17/2006
33bProvider typeFamily Medicine Physician
28Total paid$1.55M
24GClaims39,001
24DCodes billed66
24AFirst – last monthJan 2018 – Sep 2024
Compared with peers
Next to other Family Medicine Physician providers in West Virginia
Rank by total paid#28 of 202
Median peer was paid$172K
This provider vs. median9.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,507 | $386K | |
| 2019 | 1,331 | $86K | |
| 2020 | 1,500 | $129K | |
| 2021 | 1,446 | $90K | |
| 2022 | 6,423 | $231K | |
| 2023 | 15,891 | $435K | |
| 2024incomplete | 6,903 | $190K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 46% | 11,555 | 10,426 | $706K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 16% | 5,053 | 4,522 | $244K |
| 72141 | 9.2% | 719 | 668 | $143K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 6.9% | 568 | 531 | $107K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 5.9% | 936 | 874 | $91K |
| 95886 | 3.1% | 375 | 347 | $49K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 2.9% | 607 | 381 | $45K |
| 95910 | 1.1% | 105 | 102 | $17K | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | <1% | 82 | 71 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,423 | 1,257 | $13K |
| 80061 | Lipid panel | <1% | 1,342 | 1,196 | $10K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,564 | 1,447 | $8K |
54 more codes
| 36415 | Collection of venous blood by venipuncture | <1% | 2,417 | $8K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 563 | $7K |
| 22853 | <1% | 17 | $7K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,587 | $7K |
| 84439 | <1% | 1,191 | $5K | |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 305 | $5K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 172 | $5K |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 1,008 | $4K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 73 | $4K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 931 | $4K |
| 72146 | <1% | 27 | $4K | |
| 95912 | <1% | 17 | $4K | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 13 | $3K |
| 80053 | Comprehensive metabolic panel | <1% | 642 | $3K |
| 72158 | <1% | 12 | $3K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 45 | $3K |
| G8730 | Pain assessment documented as positive using a standardized tool and a follow-up plan is documented | <1% | 651 | $3K |
| 80076 | <1% | 721 | $2K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 133 | $2K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 68 | $2K |
| 99205 | Prolong outpt/office vis | <1% | 32 | $2K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 128 | $2K |
| 90686 | <1% | 103 | $1K | |
| 82607 | <1% | 175 | $1K | |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 178 | $1K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 31 | $1K |
| G2211 | Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's single, serious condition or a complex condition. (add-on code, list separately in addition to office/outpatient evaluation and management visit, new or established) | <1% | 382 | $1K |
| 81001 | <1% | 628 | $1K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 51 | $729.12 |
| 80050 | General health panel | <1% | 34 | $702.94 |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 95 | $401.40 |
| 95251 | <1% | 53 | $306.58 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 40 | $258.11 |
| 1036F | <1% | 301 | $238.34 | |
| 82043 | <1% | 62 | $232.40 | |
| G8419 | Bmi documented outside normal parameters, no follow-up plan documented, no reason given | <1% | 141 | $228.75 |
| 82570 | <1% | 62 | $218.05 | |
| 87428 | <1% | 18 | $216.39 | |
| 83540 | <1% | 44 | $188.28 | |
| 4004F | <1% | 44 | $115.83 | |
| G8752 | Most recent systolic blood pressure < 140 mmhg | <1% | 67 | $109.65 |
| G8754 | Most recent diastolic blood pressure < 90 mmhg | <1% | 73 | $109.65 |
| 99406 | <1% | 12 | $84.12 | |
| G8400 | Patient with central dual-energy x-ray absorptiometry (dxa) results not documented, reason not given | <1% | 12 | $80.82 |
| 83735 | <1% | 13 | $60.78 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 63 | $35.01 |
| 82962 | <1% | 165 | $18.18 | |
| 3074F | <1% | 34 | $0.04 | |
| 3078F | <1% | 50 | $0.01 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 519 | $0.01 |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | 0% | 109 | $0.00 |
| 1101F | 0% | 240 | $0.00 | |
| G8732 | No documentation of pain assessment, reason not given | 0% | 105 | $0.00 |
| 3079F | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFARNSWORTH, ADAM (COO)